The ACP guideline, published in Annals of Internal Medicine, includes three recommendations centered around monotherapy: ...

In a clinical guideline issued by the American College of Physicians and published online Feb. 4 in the Annals of Inte ...

Wondering how to talk to a doctor about migraine? An expert discusses common questions for your doctor to help diagnose ...

The American College of Physicians (ACP) has developed new recommendations to prevent episodic migraines in nonpregnant ...

Discover how ayurveda, an ancient healing system, can help you live better with migraine. Discover doshas, dietary strategies ...

Discover the real causes behind migraines, expert-backed treatment options, and effective strategies to prevent and manage migraine attacks.

The US FDA has approved Symbravo (meloxicam and rizatriptan) for the acute treatment of migraine with or without aura in adults.

The FDA approved an oral combination of meloxicam and rizatriptan (Symbravo) to treat adults with acute migraine with or ...

Part of the benefit may be due to BP-lowering effects of the drug and/or fewer abnormal heart rhythms, says Seemant ...

The Food and Drug Administration (FDA) has approved Symbravo ® (meloxicam/rizatriptan) for the acute treatment of migraine with or without aura in adults.

The American College of Physicians (ACP) has developed new recommendations to prevent episodic migraines in nonpregnant adults in outpatient settings.